Irache JM - Search Results

1

In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.

Prior S, Gander B, Blarer N, Merkle HP, Subirá ML, Irache JM, Gamazo C. Prior S, et al. Among authors: irache jm. Eur J Pharm Sci. 2002 Mar;15(2):197-207. doi: 10.1016/s0928-0987(01)00218-4. Eur J Pharm Sci. 2002. PMID: 11849917

2

Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.

Prior S, Gamazo C, Irache JM, Merkle HP, Gander B. Prior S, et al. Among authors: irache jm. Int J Pharm. 2000 Feb 25;196(1):115-25. doi: 10.1016/s0378-5173(99)00448-2. Int J Pharm. 2000. PMID: 10675713

3

Bioadhesive potential of gliadin nanoparticulate systems.

Arangoa MA, Ponchel G, Orecchioni AM, Renedo MJ, Duchêne D, Irache JM. Arangoa MA, et al. Among authors: irache jm. Eur J Pharm Sci. 2000 Oct;11(4):333-41. doi: 10.1016/s0928-0987(00)00121-4. Eur J Pharm Sci. 2000. PMID: 11033077

4

Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.

Merodio M, Arnedo A, Renedo MJ, Irache JM. Merodio M, et al. Among authors: irache jm. Eur J Pharm Sci. 2001 Jan;12(3):251-9. doi: 10.1016/s0928-0987(00)00169-x. Eur J Pharm Sci. 2001. PMID: 11113644

5

A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice.

Murillo M, Grilló MJ, Reñé J, Marín CM, Barberán M, Goñi MM, Blasco JM, Irache JM, Gamazo C. Murillo M, et al. Among authors: irache jm. Vaccine. 2001 Jul 20;19(30):4099-106. doi: 10.1016/s0264-410x(01)00177-3. Vaccine. 2001. PMID: 11457533

6

[Controlled liberation of active principles by means of new galenic formulations].

Murillo M, Espuelas S, Prior S, Vitas AI, Renedo MJ, Goñi MM, Irache JM, Gamazo C. Murillo M, et al. Among authors: irache jm. Rev Med Univ Navarra. 2001 Oct-Dec;45(4):19-34. Rev Med Univ Navarra. 2001. PMID: 11985214 Review. Spanish.

7

Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity.

Murillo M, Gamazo C, Irache JM, Goñi MM. Murillo M, et al. Among authors: irache jm. J Drug Target. 2002 May;10(3):211-9. doi: 10.1080/10611860290022642. J Drug Target. 2002. PMID: 12075822

8

Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.

Murillo M, Gamazo C, Goñi MM, Irache JM, Blanco-Príeto MJ. Murillo M, et al. Among authors: irache jm. Int J Pharm. 2002 Aug 21;242(1-2):341-4. doi: 10.1016/s0378-5173(02)00212-0. Int J Pharm. 2002. PMID: 12176275 Free article.

9

Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens.

Murillo M, Goñi MM, Irache JM, Arangoa MA, Blasco JM, Gamazo C. Murillo M, et al. Among authors: irache jm. J Control Release. 2002 Dec 13;85(1-3):237-46. doi: 10.1016/s0168-3659(02)00276-6. J Control Release. 2002. PMID: 12480328

10

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.

Espuelas MS, Legrand P, Campanero MA, Appel M, Chéron M, Gamazo C, Barratt G, Irache JM. Espuelas MS, et al. Among authors: irache jm. J Antimicrob Chemother. 2003 Sep;52(3):419-27. doi: 10.1093/jac/dkg351. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters